What is Rigel Pharmaceuticals Inc.'s contact information?

Rigel Pharmaceuticals Inc.'s contact information: communications@rigel.com, webmaster@rigel.com, privacy@rigel.com, +16506241100.

How many employees does Rigel Pharmaceuticals Inc. have?

Rigel Pharmaceuticals Inc. has 300 employees.

What industry does Rigel Pharmaceuticals Inc. belong to?

Rigel Pharmaceuticals Inc. is in the industry of: Biotechnology Research.

What are Rigel Pharmaceuticals Inc.'s official social media profiles?

Rigel Pharmaceuticals Inc. Linkedin Page Rigel Pharmaceuticals Inc. Twitter Page

What tech stack does Rigel Pharmaceuticals Inc. use?

Some of the popular technologies that Rigel Pharmaceuticals Inc. uses are: Google Analytics, Unpkg, Cookiebot.

What are Rigel Pharmaceuticals Inc.'s office addresses?

Rigel Pharmaceuticals Inc. has a known office at the following address: 1180 Veterans Blvd South San Francisco, CA 94080, US.

What is Rigel Pharmaceuticals Inc.'s estimated annual revenue?

Rigel Pharmaceuticals Inc.'s revenue is $80,000,000

What is Rigel Pharmaceuticals Inc.'s open headcount?

Rigel Pharmaceuticals Inc. has one job posting.

What is the number of ad campaigns for Rigel Pharmaceuticals Inc.?

Rigel Pharmaceuticals Inc. has no advertisements yet.

What is the number of recent news articles about Rigel Pharmaceuticals Inc.?

Rigel Pharmaceuticals Inc. has 4 news articles.

Rigel Pharmaceuticals Inc. - Pubrio Company Profile & Intent

Rigel Pharmaceuticals Inc.

United States · Biotechnology Research

Biotechnology Research

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with hematologic disorders and cancer.

Company Insights

choicenews.co.kr · recognized_as · 2026-01-14

Open news

KOSDAQ biotech and battery stocks decline

KOSDAQ index fell due to foreign and institutional selling, with biotech and battery stocks leading the decline. Major companies like Alteogen, Peptron, and Ecopro BM saw significant drops.

Peptron, Inc.

Rigel Pharmaceuticals Inc.

Ecopro

Alteogen Inc.

Ecopro Bm

choicenews.co.kr · launches · 2025-12-26

Open news

US stock rally continues, KOSPI and KOSDAQ rise

Korean stock markets opened higher, following US stock market gains. KOSPI rose 0.40% to 4125.25, with semiconductor stocks leading. KOSDAQ also increased by 0.43%.

한화에어로스페이스

Samsung Electronics

Lg Electronics

Hyundai Motor India Ltd.

Abl Bio Inc.

Rigel Pharmaceuticals Inc.

Sk Hynix

Alteogen Inc.

greenpostkorea.co.kr · launches · 2025-01-21

Open news

JW Pharmaceutical to launch ITP treatment in June

JW Pharmaceutical to launch Tavalisse 100·150mg for chronic adult ITP in June after MFDS approval and insurance pricing.

Mfds(Ministry Of Food And Drug Safety)

キッセイ薬品工業（株）

Rigel Pharmaceuticals Inc.

Jw Pharmaceutical Corporation

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

Coindesk

Deribit

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

Coindesk

Upbit Singapore

coinreaders.com · launches · one week ago

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Coindesk

J.P. Morgan

Get full access to view complete information

1 - 4 of 4

Frequently Asked Questions Regarding Rigel Pharmaceuticals Inc.

Company Overview

1996

Founded

Biotechnology Research

Industry

United States

Location

1,620,826

Ranking

300 employees

Size

Similar Companies

Get full access to view complete information